Photo of Henry G. Kaplan

Henry G. Kaplan, M.D.

About

Professional Statement

Dr. Kaplan is a 2018 Seattle Met Top Doctor Award winner. Philosophy of care: Try to help the patient make the most of life.

Read More

Accepts 43 Insurance Plans

Please contact the practice directly to confirm your health plan is accepted
  • Aetna Medicare Advantage HMO
  • Aetna Medicare Advantage PPO
  • Aetna PPO
  • Amerigroup Amerivantage Dual Coordination
  • Amerigroup Amerivantage HMO
  • Amerigroup Medicaid (Apple Health/Healthy Options/CHIP)
  • Beacon Health Options PPO (Behavioral Health)
  • CHPW Medicaid (Apple Health/Healthy Options/CHIP)
  • CHPW Medicare Advantage
  • Cigna Behavioral Health
  • Cigna PPO
  • Coordinated Care Ambetter HMO
  • Coordinated Care Medicaid (Apple Health/Healthy Options/CHIP)
  • Coventry/First Health PPO
  • First Choice PPO
  • HealthSmart (Interplan) PPO
  • Humana Medicare Advantage
  • Humana PPO
  • Kaiser (Contract Limitations)
  • Medicaid of Washington
  • Medicare
  • Molina Exchange HMO
  • Molina Medicaid (Apple Health/Healthy Options/CHIP)
  • Molina Medicare Advantage
  • Multiplan PPO
  • Optum
  • PacMed USFHP
  • Premera Heritage
  • Premera Heritage Signature
  • Premera Medicare Advantage HMO
  • Providence Health Plan Medicare Advantage
  • Regence MedAdvantage PPO
  • Regence PPO
  • TRICARE
  • Triwest VAPC3/Choice Card
  • United Behavioral Health Medicaid
  • United Behavioral Health Medicare Advantage
  • United Behavioral Health PPO
  • United HealthCare HMO
  • United HealthCare Medicaid (Apple Health/Healthy Options/CHIP)
  • United HealthCare Medicare Advantage
  • United HealthCare PPO
  • Workers' Compensation (L&I)
Read More

Education

University of Rochester School of Medicine and Dentistry
medical school, 1972
University of Washington School of Medicine
internship, Internal Medicine, Oncology, 1973
University of Washington School of Medicine
residency, Internal Medicine, Oncology, 1977
University of Washington School of Medicine
fellowship, Oncology, 1977
National Cancer Institute/National Institutes of Health - Clinical Associate
fellowship

Board Certifications

American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Medical Oncology

Clinical Interests

  • Abnormal Mammogram
  • Amyloidosis
  • Anemia
  • Aromatase Inhibitor
  • B12 Deficiency Anemia
  • Blood Cancer
  • Bone Marrow Transplant
  • Bone Tumor
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Follow Up
  • Breast Cancer Genetics
  • Breast Cancer Genomics
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Survivorship
  • Carcinoma In Situ Of Breast
  • Colorectal Malignancy
  • Dysplasia Of Breast
  • Egfr Mutation
  • Endocrine Complications Of Cancer Therapy
  • Er Positive Breast Cancer
  • Family History Of Breast Cancer
  • Head And Neck Cancer Care
  • Hellp Syndrome
  • Hemochromatosis
  • Hemolytic Uremic Syndrome
  • Heparin Induced Thrombocytopenia
  • Herceptin
  • Hereditary Spherocytosis
  • Histiocytosis
  • Hormone Replacement Therapy
  • Hypogammaglobulinemia
  • Idiopathic Thrombocytopenic Purpura
  • Iron Deficiency Anemia
  • Leukemia
  • Leukopenia
  • Lymphoma
  • Male Breast Cancer
  • Mammogram
  • Maternal Hematologic Disorders
  • Metastatic Breast Cancer
  • Microcalcifications
  • Multiple Myeloma
  • Myelodysplasia
  • Myelodysplastic Syndrome
  • Neutropenia
  • Pancytopenia
  • Paroxysmal Nocturnal Hemoglobinuria
  • Petechiae
  • Plasma Cell Dyscrasia
  • Polycythemia
  • Pulmonary Metastases
  • Purpura
  • Radiation Treatment For Breast Cancer
  • Renal Cancer
  • Rh Incompatibility
  • Sarcoma
  • Secondary Polycythemia
  • Sentinel Node Biopsy
  • Splenomegaly
  • Teratogen Exposure
  • Testicular Cancer
  • Thalassemia
  • Thrombocytopenia
  • Thrombophilia
  • Thrombotic Thrombocytopenic Purpura
  • Unknown Primary Cancer
Read More

Personal Interests

hiking, backpacking, photography
Read More

Publications

  • Ryu RJ, Eyal S, Kaplan HG, Akbarzadeh A, Hays K, Puhl K, Easterling TR, Berg SL, Scorsone KA, Feldman EM, Umans JG, Miodovnik M, Hebert MF. Ryu RJ, Eyal S, Kaplan HG, Akbarzadeh A, Hays K, Puhl K, Easterling TR, Berg SL, Scorsone KA, Feldman EM, Umans JG, Miodovnik M, Hebert MF. Pharmacokinetics of doxorubicin in pregnant women. Cancer Chemother Pharmacol. 2014 Apr; 73(4):789-97.
  • Kaplan HG. Vemurafenib treatment of BRAF V600E-mutated malignant peripheral nerve sheath tumor J Natl Compr Canc Netw. 2013 Dec 1;11 (12):1466-70.
  • Kaplan HG, Malmgren JA, Li CI, Calip GS. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors. Breast Cancer Res Treat. 2013 Dec; 142(3):629-36.
  • Kaplan HG, Malmgren JA, Atwood MK. Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women. J Geriatr Oncol. 2013 Apr;4(2):148-56. doi: 10.1016/j.jgo.2012.12.007. Epub 2013 Jan 23.
  • Nassiri F, Scheithauer BW, Corwin DJ, Kaplan HG, Mayberg M, Cusimano MD, Rotondo F, Kovacs K. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013 Jun 1;4:74.
  • Kaplan HG, Malmgren JA. The breast cancer overdiagnosis conundrum: an oncologist's viewpoint. Ann Intern Med. 2013 Jan 1;158(1):60-1.
  • Yee D, Haddad T, Albain K, Barker A, Benz C, Boughey J, Buxton M, Chien AJ, DeMichele A, Dilts D, Elias A, Haluska P, Hogarth M, Hu A, Hytlon N, Kaplan HG, Kelloff GG, Khan Q, Lang J, Leyland-Jones B, Liu M, Nanda R, Northfelt D, Olopade OI, Park J, Parker B, Parkinson D, Pearson-White S, Perlmutter J, Pusztai L, Symmans F, Rugo H, Tripathy D, Wallace A, Wholley D, Van't Veer L, Berry DA, Esserman L. Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development. J Clin Oncol. 2012 Dec 20;30(36):4584-6.
  • Malmgren JA, Parikh J, Atwood MK, KAPLAN HG. Impact of mammography detection on the course of breast cancer in women aged 40-49 years. Radiology. 2012 Mar; 262(3):797-806.
  • KAPLAN, H.G., Malmgren, J.A., and Atwood, M.K.: “Increased Incidence of Myelodysplastic Syndrome and Acute Myeloid Leukemia Following Breast Cancer Treatment with Radiation Alone or In Combination with Chemotherapy: A Registry Cohort Analysis 1990-2005,” BMC Cancer 11:260; 2011.
  • Malmgren, J.A., Atwood, M.K., and KAPLAN, H.G.: “Mammography Detected Breast Cancer Over Time Among Patients 75 and Older at a Community Based Cancer Center:1990-2008,” Amer Soc Clin Onc, 29(15S):#9086;2011.
  • KAPLAN, H.G., Malmgren, J.A., Atwood, M, Goldstein, L.C.: “Positive Response to Neoadjuvant Cyclophosphamide and Doxorubicin in Topoisomerase II Non-Amplified/Her2/neu negative/Polysomy 17 Absent Breast Cancer Patients,” Cancer Mgmt & Res, 2:213-218;2010.
  • KAPLAN, H.G., Malmgren, J.A., and Atwood, M.: “T1N0 Triple Negative Breast Cancer: Risk Recurrence and Adjuvant Chemotherapy,” Breast J 15(5):454-460; 2009.
  • Witzig, T.E., Wiernik, P.H., Moore, T., Reeder, C., Coe, C., Justice, G., KAPLAN, H., Voralia, M., Pietronigro, D., Takeshita, K., Ervin-Hayes, A., Zeldis, J.B., and Vose, J.M.: “Phase II Multi-Center Study of Lenalidomide Oral Monotherapy in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma,” J Clin Onc, 27(32):5404-9;2009.
  • Malmgren, J.A., Atwood, M., and KAPLAN, H.: “Increase in Mammography Detected Breast Cancer Over Time at a Community Based Regional Cancer Center: A Longitudinal Cohort Study, 1990 – 2005,” BMC Cancer 8:131-7;2008.
  • Vemulakonda, V.M., Lendvay, T.S., Shnorhavorian, M., Joyner, B.D., KAPLAN, H., Mitchell, M.E., and Grady, R.W.: “Metastatic Adenocarcinoma after Augmentation Gastrocystoplasty, J Urology 179(3):1094-7;2008.
  • KAPLAN, H.G., and Malmgren, J.A.: “Impact of Triple Negative Phenotype on Breast Cancer Prognosis,” Breast J 14(5):456-463;2008.
  • KAPLAN, H.G., Malmgren, J.A., and Atwood, M.: “Impact of Detection Method on the Course of Breast Cancer: Patient versus Mammography Detected,” Clin. Breast Cancer, 7(2):133-140;2006.
  • KAPLAN, H.G., Malmgren, J.A., and Atwood, M.: “Leukemia Incidence Post Primary Breast Cancer Treatment,” Cancer 101:1529-1536; 2004.
  • Perez, E., Navari, R.M., KAPLAN, H.G., Gralla, R.J., Grunberg, S.M., Palmer, R., and Fitts, D.: “Antiemetic Efficacy and Safety of Different Doses of Granisetron in Patients Receiving Platinum,” Support. Care Cancer 5:31; 1997.
  • Navari, R.M., KAPLAN, H.G., Gralla, R.J., Grunberg, S.M., Palmer, R., and Fitts, D.: “Efficacy and Safety of Granisetron, A Selective 5-HT3 Antagonist, In the Prevention of Nausea and Vomiting Induced by High Dose Platinum,” J. Clin. Oncol. 12:2204; 1994.
  • KAPLAN, H.G.: “Cancer Chemotherapy in the Elderly,” in Vestal, R., ed., Drug Therapy in the Elderly, Addis Press, Auckland, 1984, pp. 338-350.
  • Larson, E.B., Scott, D.H., and KAPLAN, H.G.: “Inadequate Medical Order Writing – A Source of Confusion and Increased Costs,” Western J. Med. 139:50; 1983.
  • Wiemann, M.C., Cummings, F.J., KAPLAN, H.G., Spermuli, E.N., Doolittle, C.H., and Calabresi, P.: “Clinical and Pharmacological Studies of Methotrexate-Minimal Leucovorin Rescue Plus 5-Fluorouracil,” Cancer Res. 42:3896; 1982.
  • KAPLAN, H.G., Appelbaum, F.R., Cheever, M.A., Greenberg, P.D., Wood, T., and Fefer, A.: “Treatment of Refractory Acute Non-Lymphocytic Leukemia with A Combination of Pyrazofuran and Cytosine Arabinoside,” Cancer Treat. Rep. 66:1397; 1982.
  • Fefer, A., Cheever, M.A., Greenberg, P.D., Appelbaum, F.R., Boyd, C.N., Buckner, C.D., KAPLAN, H.G., Ramberg, R., Sanders, J.E., Storb, R., and Thomas, E.D.: “Treatment of Chronic Granulocytic Leukemia with Chemoradiotherapy and Transplantation of Marrow from Identical Twins.” New England J. Med. 306:63; 1982.
  • Appelbaum, F.R., Fefer, A., Cheever, M.A., Buckner, C.D., Greenberg, P.D., KAPLAN, H.G., Storb, R., and Thomas, E.D.: “Treatment of Non-Hodgkin’s Lymphoma with Marrow Transplantation in Identical Twins,” Blood 58:509; 1981.
  • Larson, S.M., Weiden, P.L., Grunbaum, Z., Rasey, J.S., KAPLAN, H.G., Graham, M.M., Harp, G., Sale, G.E., and Williams, D.L.: “Positron Imaging Feasibility Studies I: Characteristics of 3H-Thymidine Uptake in Rodent and Canine Neoplasms,” J. Nucl. Med. 22:875; 1981.
  • Fefer, A., Cheever, M.A., Thomas, E.D., Appelbaum, F.R., Buckner, C.D., Clift, R.A., Glucksberg, H., Greenberg, P.D., Johnson, F.L., KAPLAN, H.G., Sanders, J.E., and Storb, R.: “Bone Marrow Transplantation for Refractory Acute Leukemia in 34 Patients with Identical Twins,” Blood 57:421; 1981. KAPLAN, H.G.: “Inhibition of Buttermilk Xanthine Oxidase by Folate Analogues And Derivatives,” Biochem. Pharmacol. 29:2135; 1980.
  • KAPLAN, H.G., and Doolittle, C.: “Hodgkin’s Disease Presenting as Steroid-Dependent Pancytopenia,” Cancer 45:3114; 1980.
  • KAPLAN, H.G., Bakken, J., Quadracci, L., and Schubach, W.: “Hepatitis Caused by Repeated Sniffing of Halothane,” Annals Int. Med. 97:797; 1979.
  • Cummings, F.J., Stoller, R.G., KAPLAN, H.G., and Calabresi, P.: “A Clincial Study of Pyrazofuran,” Cancer Treat. Rep. 63:1363; 1979.
  • Stoller, R.G., KAPLAN, H.G., Cummings, F.J., and Calabresi, P.: “A Clinical and Pharmacological Study of High-Dose Methotrexate with Minimal Leucovorin Rescue,” Cancer Res.39:908; 1979.
  • KAPLAN, H.G., and Myers, C.E.: “Complex Inhibition of Thymidylate Synthetase By Aromatic Diamidines: Evidence for Both Rapid, Freely Reversible and Slowly Progressive Non-Equilibrium Inhibition,” J. Pharm. Exptl. Therap.201:554; 1977.
  • Friedman, J, KAPLAN, H., and Hall, J.: “The Jeune Syndrome (Asphyxiating Thoracic Dystrophy) in an Adult,” Amer. J. Med. 59:875; 1975.
  • Miller, D.R., and KAPLAN, H.G.: “Reduced NBT Dye Reduction in Phagocytes Of Patients Receiving Prednisone,” Pediatrics 45:861; 1970.
Read More

Professional Associations

AOA, ASCO, AACR, ASBD, NS Society, AMA, WSMA
Read More

Languages

  • English

Practice Locations

Henry G. Kaplan practices at one location

Medical Oncology First Hill - True Center
1221 Madison Street
Floor 5

Seattle, WA 98104
Affiliated Facilities
  • Swedish Cherry Hill
  • Swedish Edmonds
  • Swedish First Hill
Medical Groups
Swedish Medical Group logo